Major catalysts coming for Cara Therapeutics, Incyte, and TG Therapeutics
Bluebird Bio getting closer to its first commercial drug
The end of flu shots?
Biogen to pay Ionis $1 billion for brain drug development
*please scroll down for all the latest news*
For banking news and anonymous forums, be sure to check out cafebanking.com